Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2003691000001112 | Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2003701000001112 | Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has AMP | Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Is a | Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has excipient | Benzalkonium chloride | false | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has excipient | Edetate disodium | false | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has specific active ingredient | Olopatadine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has specific active ingredient | Mometasone furoate | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Olopatadine | true | Inferred relationship | Existential restriction modifier | ||
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR